Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on July 14, 2005

Arteriosclerosis, Thrombosis, and Vascular Biology. 2005
Published online before print July 14, 2005, doi: 10.1161/01.ATV.0000177808.92494.14
A more recent version of this article appeared on September 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/9/1843    most recent
01.ATV.0000177808.92494.14v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rookmaaker, M. B.
Right arrow Articles by van Hinsbergh, V. W.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rookmaaker, M. B.
Right arrow Articles by van Hinsbergh, V. W.M.

Submitted on December 29, 2003
Accepted on July 1, 2005

CD34+ Cells Home, Proliferate, and Participate in Capillary Formation, and in Combination With CD34- Cells Enhance Tube Formation in a 3-Dimensional Matrix

Maarten B. Rookmaaker ; Marianne C. Verhaar *; Cindy J.M. Loomans ; Robert Verloop ; Erna Peters ; Peter E. Westerweel ; Toyoaki Murohara ; Frank J.T. Staal ; Anton Jan van Zonneveld ; Pieter Koolwijk ; Ton J. Rabelink ; and Victor W.M. van Hinsbergh

From the Department of Vascular Medicine (M.B.R., M.C.V., P.E.W.), University Medical Center Utrecht, the Netherlands; the Department of Nephrology (C.J.M.L., A.J.v.Z., T.J.R.), Leiden University Medical Center, Leiden, the Netherlands; the Department of Immunology (C.J.M.L., F.J.T.S.), Erasmus Medical Center, Rotterdam, the Netherlands; the Department of Biomedical Research (E.P., P.K.), Gaubius Laboratory TNO-PG, Leiden, the Netherlands; the Department of Cardiology (T.M.), Nagoya University Graduate School of Medicine, Japan; and the Department of Physiology (R.V., V.W.M.H.), VU University Medical Center, Amsterdam, the Netherlands.

* To whom correspondence should be addressed. E-mail: m.c.verhaar{at}azu.nl.

Objective--Emerging evidence suggests that human blood contains bone marrow (BM)-derived endothelial progenitor cells that contribute to postnatal neovascularization. Clinical trials demonstrated that administration of BM-cells can enhance neovascularization. Most studies, however, used crude cell populations. Identifying the role of different cell populations is important for developing improved cellular therapies.

Methods and Results--Effects of the hematopoietic stem cell-containing CD34+ cell population on migration, proliferation, differentiation, stimulation of, and participation in capillary-like tubule formation were assessed in an in vitro 3-dimensional matrix model using human microvascular endothelial cells. During movement over the endothelial monolayer, CD34+ cells remained stuck at sites of capillary tube formation and time- and dose-dependently formed cell clusters. Immunohistochemistry confirmed homing and proliferation of CD34+ cells in and around capillary sprouts. CD34+ cells were transduced with the LNGFR marker gene to allow tracing. LNGFR gene-transduced CD34+ cells integrated in the tubular structures and stained positive for CD31 and UEA-1. CD34+ cells alone stimulated neovascularization by 17%. Coculture with CD34- cells led to 68% enhancement of neovascularization, whereas CD34- cells displayed a variable response by themselves. Cell-cell contact between CD34+ and CD34- cells facilitated endothelial differentiation of CD34+ cells.

Conclusions--Our data suggest that administration of CD34+-enriched cell populations may significantly improve neovascularization and point at an important supportive role for (endogenous or exogenous) CD34- cells.




This article has been cited by other articles:


Home page
StrokeHome page
R. P.W. Rouhl, R. J. van Oostenbrugge, J. Damoiseaux, J.-W. C. Tervaert, and J. Lodder
Endothelial Progenitor Cell Research in Stroke: A Potential Shift in Pathophysiological and Therapeutical Concepts
Stroke, July 1, 2008; 39(7): 2158 - 2165.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. B. Rookmaaker, M. C. Verhaar, H. C. de Boer, R. Goldschmeding, J. A. Joles, H. A. Koomans, H.-J. Grone, and T. J. Rabelink
Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F624 - F630.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
A. Casamassimi, M. L. Balestrieri, C. Fiorito, C. Schiano, C. Maione, R. Rossiello, V. Grimaldi, V. Del Giudice, C. Balestrieri, B. Farzati, et al.
Comparison Between Total Endothelial Progenitor Cell Isolation Versus Enriched Cd133+ Culture
J. Biochem., April 1, 2007; 141(4): 503 - 511.
[Abstract] [Full Text] [PDF]